在B细胞淋巴瘤中刻板印象的B细胞受体免疫球蛋白
Andreas Agathangelidis1, Athanasios Roussos2, Konstantinos Kardamiliotis2
1Division of Genetics & Biotechnology, Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Methods in molecular biology (Clifton, N.J.)
|October 18, 2024
概括
成熟的B细胞恶性瘤显示受限制的B细胞受体免疫球蛋白 (BcR IG) 基因序列,识别了刻板印象的BcR IG子集. 这表明了常见的表位选择,有助于理解疾病进展和风险分层.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 成熟的B细胞恶性瘤表现出显著的B细胞受体免疫球蛋白 (BcR IG) 基因重组序列限制.
- 标识刻板的BCRIG子集表明瘤发育中的常见表位体的选择.
- 在慢性淋巴细胞白血病 (CLL),地幔细胞淋巴瘤 (MCL) 和脏边缘区域淋巴瘤 (SMZL) 中发现了刻板的BCRIG.
研究的目的:
- 提供最近关于成熟B细胞恶性瘤中BcRIG刻板印象的研究概述.
- 为确定刻板印象的BcR IG.的识别划出方法方法的方法.
- 突出基于BCRIG刻板印象的分子亚分类的生物学和临床相关性.
主要方法:
- 对克隆型B细胞受体免疫球蛋白 (BcR IG) 基因重排序的检查.
- 不同成熟的B细胞恶性瘤实体之间的比较分析.
- 审查BcRIG识别的过去和现在的方法.
主要成果:
- 在成熟的B细胞恶性瘤中显著地限制了谱系,并确定了刻板印象的BcR IG子集.
- 刻板印象IGs主要是"疾病偏差",表明不同的病原性轨迹.
- 在CLL中,同一个刻板印象的小组中的患者共享一致的生物学背景和临床过程.
结论:
- 基于BcR IG刻板印象的成熟B细胞恶性瘤的分子亚分类具有生物学和临床相关性.
- 将其分配给刻板印象的子集可以帮助揭示疾病发病/进展机制.
- 刻板的BcRIG分析对于完善成熟B细胞恶性瘤患者风险分层有价值.
关键词:
B细胞受体 B细胞受体在IGHV基因的基因.免疫遗传学 免疫遗传学免疫球蛋白是一种免疫球蛋白.单克隆B细胞淋巴细胞症.本体发生学是什么意思?身体上的超变异性突变.陈词滥调是一种刻板印象.慢性淋巴细胞白血病 慢性淋巴细胞白血病更多相关视频
相关概念视频
Diversity of Antigen Receptors
531
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
531
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Antibody Structure and Classes
841
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
841
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Antibody Structure
59.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.3K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


